Track topics on Twitter Track topics that are important to you
// Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due The post SMi’s 3rd annual conference – Immunogenicity...
Given the number of effective treatments for type II diabetes, which have good evidence about safety and efficacy, should any new drugs for the condition be subject to a higher regulatory bar? In this...
On April 6th - 8th, SynBioBeta with support of event host SynbiCITE, will once again bring together the synthetic biology community for the fourth annual SynBioBeta London 2016 Conference at Impe...
LONDON, Ala. (PRWEB) October 22, 2015 When author David Johnson was diagnosed with type 2 diabetes , he knew he wasnât going...
David SalazarHDMA’s Third Annual International Pharmaceutical Distribution Conference will take place in London from Sept. 12-13 and it is co-hosted with various European healthcare distri...
A modeling study projects that one in two Mexicans could have diabetes by 2050; diabetes diagnoses in Mexican adults skyrocketed by 30% from 2000 to 2012. Medscape Medical News
Diabetes is a major cause of death and disability worldwide. In 2012 it caused as many deaths as HIV/AIDS (1·5 million).1 Disability resulting from diabetes has grown substantially since 1990, with p...
London 2012 partner GlaxoSmithKline (GSK) today signed a long-term agreement with the World Anti-Doping Agency (WADA) that will help the agency create early detection methods for medicines that have p...
Type 2 Diabetes (T2DM) is the most rapidly increasing risk factor for ischemic stroke. We aimed to compare trends in outcomes for ischemic stroke in people with or without diabetes in Spain between 20...
Diabetes Mellitus is one of the major public health challenges, affecting more than 347 million adults worldwide. The impact of diabetes necessitates assessing the quality of care received by people w...